Ashwagandha

Umxholo

• Inokwenzeka ukuba isebenze ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

I-Ashwagandha sisihlahla esincinci esihlala sihlaza. Ikhula eIndiya, kuMbindi Mpuma, nakwezinye iindawo zaseAfrika. Ingcambu kunye namaqunube zisetyenziselwa ukwenza amayeza.

I-Ashwagandha iqhele ukusetyenziselwa uxinzelelo. Ikwasetyenziswa njenge "adaptogen" yezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.

Sukuphambanisa i-ashwagandha nePhysalis alkekengi. Zombini ziyaziwa njengecherry yasebusika. Kwakhona, sukuphambanisa i-ashwagandha kunye ne-ginseng yaseMelika, iPanax ginseng, okanye eleuthero.

Isifo seCoronavirus 2019 (COVID-19): Akukho bungqina bokuba uxhase usebenzisa i-ashwagandha ye-COVID-19. Landela ukhetho lokuphila olusempilweni kunye neendlela zothintelo eziqinisekisiweyo endaweni yoko.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe ASHWAGANDHA zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

• Uxinzelelo. Olunye uphando lubonisa ukuba ukuthatha isicatshulwa esithile se-ashwagandha (KSM66, Ixoreal Biomed) i-300 mg kabini yonke imihla emva kokutya okanye esinye isicatshulwa esithile (i-Shoden, i-Arjuna Natural Ltd.) i-240 mg mihla le kwiintsuku ezingama-60 kubonakala ngathi kuphucula iimpawu zoxinzelelo.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukwaluphala. Uphando lwakwangoko lubonisa ukuba ukuthatha ingcambu ye-ashwagandha kunceda ukuphucula impilo, umgangatho wokulala, kunye nokuqaqanjelwa kwengqondo ngamanani amancinci ukuya kumodareyitha kubantu abaneminyaka eyi-65-80 iminyaka.
• Iziphumo ebezingalindelekanga ezibangelwa zii-antipsychotic drug. I-Antipsychotic isetyenziselwa ukunyanga i-schizophrenia kodwa inokubangela amanqanaba amafutha kunye neswekile egazini ukuba inyuke. Ukuthatha isicatshulwa esithile se-ashwagandha (Cap Strelaxin, M / s Pharmanza Herbal Pvt. Ltd.) 400 mg kathathu ngemini inyanga enye kunokunciphisa amanqanaba eswekile kunye neswekile egazini kubantu abasebenzisa la mayeza.
• Ixhala. Olunye uphando lwakwangoko lubonisa ukuba ukuthatha i-ashwagandha kunokunciphisa ezinye iimpawu zoxinzelelo.
• Ukusebenza kwezemidlalo. Olunye uphando lubonisa ukuba ukuthatha i-ashwagandha kunceda malunga neoksijini engakanani umzimba onokuyisebenzisa ngexesha lokuzilolonga. Kodwa akwaziwa ukuba oku kuyanceda ukuphucula ukusebenza.
• Ukuxhuzula. Ukuthatha isicatshulwa esithile se-ashwagandha (iSensoril, Natreon, Inc.) kwiiveki ze-8 kunokuphucula ukusebenza kwengqondo kubantu abanyangwa isifo sokuphazamiseka kwengqondo.
• Ukudinwa kwabantu abaphathwe ngamachiza omhlaza. Uphando lwakwangoko lubonisa ukuthatha i-ashwagandha ethile ekhutshwe ngo-2000 mg (iHimalaya Drug Co, New Delhi, India) ngexesha lonyango lwe-chemotherapy lunokunciphisa iimvakalelo zokudinwa.
• Seswekile. Kukho ubungqina bokuba i-ashwagandha inokunciphisa amanqanaba eswekile yegazi kubantu abanesifo seswekile.
• Uhlobo loxinzelelo oluqhubekayo oluphawulwe kukuxhalaba okugqithisileyo kunye noxinzelelo (isifo soxinzelelo ngokubanzi okanye i-GAD). Olunye uphando lokuqala lweklinikhi lubonisa ukuba ukuthatha i-ashwagandha kunokunciphisa ezinye iimpawu zoxinzelelo.
• Cholesterol ephezulu. Kukho ubungqina bokuba i-ashwagandha inokunciphisa amanqanaba e-cholesterol kwizigulana ezine-cholesterol ephezulu.
• Ukungasebenzi kwe-thyroid (hypothyroidism). Abantu abane-thyroid engasebenziyo banamazinga aphezulu egazi ehomoni ebizwa ngokuba yi-thyroid stimulating hormone (TSH). Abantu abane-thyroid engasebenziyo banokuba namazinga aphantsi e-hormone ye-thyroid. Ukuthatha i-ashwagandha kubonakala ngathi kunciphisa i-TSH kunye nokwandisa amanqanaba e-thyroid kubantu abanefomu encinci ye-thyroid engasebenzi.
• Ukuphuthelwa. Olunye uphando lubonisa ukuba ukuthatha i-ashwagandha kunokunceda abantu balale ngcono.
• Imiqathango kwindoda emthintelayo ekufumaneni umfazi okhulelweyo kungaphelanga nonyaka wokuzama ukukhulelwa (ukungachumi kwendoda)Olunye uphando lwakwangoko lubonisa ukuba i-ashwagandha inokuphucula umgangatho wesidoda kunye nokubala kwesidoda kumadoda angenazintsholongwane. Kodwa akucaci ukuba i-ashwagandha ingayiphucula nyani inzala.
• Uhlobo loxinzelelo oluphawulwe ziingcinga eziphindaphindayo kunye nokuziphatha okuphindaphindayo (ukuphazamiseka okungafunekiyo okanye i-OCD). Uphando lwakwangoko lubonisa ukuba ingcambu ye-ashwagandha inokunciphisa iimpawu ze-OCD xa ithathwa ngamayeza amiselweyo kwiiveki ezi-6.
• Iingxaki zesondo ezithintela ukoneliseka ngexesha lokwabelana ngesondo. Uphando lwakwangoko lubonisa ukuba ukuthatha i-ashwagandha kukhutshwa yonke imihla kwiiveki ze-8 kunye nokufumana iingcebiso kukonyusa umdla kwezokwabelana ngesondo kunye nokwoneliseka ngokwesondo kubantu abadala ababhinqileyo abanesifo esingasebenzi kakuhle kunesiluleko sisodwa.
• Ukuqwalaselwa kwentsilelo-yokuchaphazeleka kwengqondo (ADHD).
• Ukulimala kwengqondo okuchaphazela ukuhamba kwemisipha (i-cerebellar ataxia).
• Osteoarthritis.
• Isifo seParkinson.
• Isifo samathambo (RA).
• Ukuguqula ukusebenza kwamajoni omzimba.
• Fibromyalgia.
• Ukunciphisa ukugabha.
• Iingxaki zesibindi.
• Ukudumba (ukudumba).
• Amathumba.
• Isifo sephepha.
• Izilonda, xa zisetyenziswa kulusu.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-ashwagandha kwezi zinto zisetyenziswayo.

I-Ashwagandha iqulethe iikhemikhali ezinokukunceda ukuzola kwengqondo, ukunciphisa ukudumba (ukudumba), uxinzelelo lwegazi olusezantsi, kunye nokuguqula amajoni omzimba.

Xa kuthathwa ngomlomo: I-Ashwagandha yiyo UKHUSELEKO OLUNOKWENZEKA xa ithathwa ukuya kuthi ga kwiinyanga ezi-3. Ukhuseleko lwexesha elide lwe-ashwagandha alwaziwa. Iidosi ezinkulu ze-ashwagandha zinokubangela isisu, isisu esihambisayo kunye nokugabha. Rhoqo, iingxaki zesibindi zinokwenzeka.

Xa isetyenziswa eluswiniAkukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba i-ashwagandha ikhuselekile okanye ziziphi iziphumo ebezingalindelekanga ezinokuba zikho.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Yi NGOKUFANELEKILEYO ukusebenzisa i-ashwagandha xa ukhulelwe. Kukho ubungqina bokuba i-ashwagandha inokubangela ukuphuphuma kwesisu. Akukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba i-ashwagandha ikhuselekile ukuba ingasetyenziswa xa uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

"Izifo zokuzikhusela komzimba" ezinjenge-multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), isifo samathambo (RA), okanye ezinye iimeko: I-Ashwagandha inokubangela ukuba amajoni omzimba asebenze ngakumbi, kwaye oku kunganyusa iimpawu zezifo ezikhuselayo. Ukuba unayo enye yezi meko, kungcono ukunqanda ukusebenzisa i-ashwagandha.

Ugqirha: I-Ashwagandha inokucothisa inkqubo yovalo. Ababoneleli ngezempilo banexhala lokuba i-anesthesia kunye namanye amayeza ngexesha nasemva kotyando lunokunyusa oku. Yeka ukuthatha i-ashwagandha ubuncinci kwiiveki ezi-2 ngaphambi kotyando olucwangcisiweyo.

Iingxaki ze-thyroid: I-Ashwagandha inokunyusa amanqanaba ehomoni ye-thyroid. I-Ashwagandha kufuneka isetyenziswe ngononophelo okanye ithintelwe ukuba unengxaki ye-thyroid okanye uthathe amayeza e-thyroid.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza eswekile (iziyobisi zeAntidiabetes)

I-Ashwagandha inokunciphisa amanqanaba eswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha i-ashwagandha kunye namayeza eswekile kunokubangela ukuba iswekile yegazi lakho lihle kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-metformin (iGlucophage), i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbotide Orinase), kunye nabanye.

Amayeza oxinzelelo lwegazi oluphezulu (iziyobisi ezichasayo)

I-Ashwagandha inokunciphisa uxinzelelo lwegazi. Ukuthatha i-ashwagandha ngamayeza asetyenziselwa ukunyanga uxinzelelo lwegazi kunokubangela ukuba amanqanaba oxinzelelo lwegazi aye ezantsi.

Amanye amayeza oxinzelelo lwegazi aphezulu abandakanya i-captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), kunye nabanye abaninzi. .

Amayeza anciphisa amajoni omzimba (i-Immunosuppressants)

I-Ashwagandha ibonakala ngathi yenza ukuba amajoni omzimba asebenze ngakumbi. Ukuthatha i-ashwagandha kunye namayeza anciphisa amajoni omzimba kunokunciphisa ukusebenza kwala mayeza.

Amanye amayeza anciphisa amajoni omzimba abandakanya i-azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf ), Sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids) kunye nabanye.

Amayeza okuthambisa (i-Benzodiazepines)

I-Ashwagandha inokubangela ukozela nokozela. Iziyobisi ezibangela ukulala nokozela zibizwa ngokuba ziindlela zokuthomalalisa. Ukuthatha i-ashwagandha kunye namayeza okuthambisa kunokubangela ukulala kakhulu.

Olunye lala mayeza okuthambisa abandakanya i-clonazepam (Klonopin), diazepam (Valium), lorazepam (Ativan), alprazolam (Xanax), flurazepam (Dalmane), midazolam (Versed), kunye nabanye.

Amayeza okudambisa (i-CNS depressants)

I-Ashwagandha inokubangela ukozela nokozela. Amayeza abangela ubuthongo abizwa ngokuba kukuthomalalisa. Ukuthatha i-ashwagandha kunye namayeza okuthambisa kunokubangela ukulala kakhulu.

Amanye amayeza okuthambisa afaka i-clonazepam (iKlonopin), i-lorazepam (Ativan), i-phenobarbital (i-Donnatal), i-zolpidem (i-Ambien) kunye nezinye.

Idlala lengqula

Umzimba ngokwendalo uvelisa iihomoni ze-thyroid. I-Ashwagandha inokunyusa ukuba ingakanani i-hormone ye-thyroid eyenziwa ngumzimba. Ukuthatha i-ashwagandha ngeepilisi zehomoni ye-thyroid kunokubangela i-hormone yegciwane emzimbeni, kwaye kwandise iziphumo kunye nemiphumo emibi ye-hormone ye-thyroid.

Iherbs kunye nezongezo ezinokunciphisa uxinzelelo lwegazi

I-Ashwagandha inokunciphisa uxinzelelo lwegazi. Ukudibanisa i-ashwagandha kunye namanye amayeza kunye nezongezo ezihlisa uxinzelelo lwegazi kunokubangela ukuba uxinzelelo lwegazi luye ezantsi. Ezinye izityalo kunye nezongezo zolu hlobo zibandakanya i-andrographis, i-casein peptides, i-claw's cat, i-coenzyme Q-10, i-oyile yentlanzi, i-L-arginine, i-lyceum, i-nettle neting, i-theanine, kunye nezinye.

Iherbs kunye nezongezelelo ezineempawu zokuthomalalisa

I-Ashwagandha inokusebenza njengokuthomalalisa. Oko kukuthi, kunokubangela ukulala. Ukuyisebenzisa kunye namanye amayeza kunye nezongezo ezisebenza njengezidambisi ezinokubangela ukulala kakhulu. Ezinye zazo zibandakanya i-5-HTP, i-calamus, i-poppy yaseCalifornia, i-catnip, i-hops, i-dogwood yaseJamaican, i-kava, iSt John's wort, i-skullcap, i-valerian, i-yerba mansa, kunye nezinye.

Akukho kunxibelelana kwaziwayo nokutya.

NGOMLOMO:

• Yoxinzelelo: Ingcambu ye-Ashwagandha ikhupha i-300 mg kabini yonke imihla emva kokutya (i-KSM66, i-Ixoreal Biomed) okanye i-240 mg yonke imihla (iShoden, iArjuna Natural Ltd.) kangangeentsuku ezingama-60.

Ajagandha, Amangura, Amukkirag, Asan, Asana, Asgand, Asgandh, Asgandha, Ashagandha, Ashvagandha, Ashwaganda, Ashwanga, Asoda, Asundha, Asvagandha, Aswagandha, Avarada, Ayurvedic Ginseng, Cerise d'Hiver, Asheroda Grey , Ginseng Indien, Hayahvaya, Indian Ginseng, Kanaje Hindi, Kuthmithi, Orovale, Peyette, Physalis somnifera, Samm Al Ferakh, Samm Al Rerakh, Sogade-Beru, Strychnos, Turangi-Ghanda, Vajigandha, Winter Cherry, Withania, Withania somnifera.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UDeshpande A, Irani N, uBalkrishnan R, uBenny IR. Isifundo esilawulwa ngokungahleliwe, esingaboniyo kabini, esilawulwa yi-placebo ukuvavanya iziphumo ze-ashwagandha (Withania somnifera) yokukhupha kumgangatho wokulala kubantu abadala abasempilweni. Ukulala ngeMed. Ngo-2020; 72: 28-36. Jonga i-abstract.
2. I-Fuladi S, i-Emami SA, i-Mohammadpour AH, i-Karimani A, i-Manteghi AA, i-Sahebkar A. Uvavanyo lwe-Andania somnifera ingcambu ikhupha ukusebenza kakuhle kwizigulana ezinengxaki yoxinzelelo ngokubanzi: Uvavanyo olulawulwa ngokungaqhelekanga lwe-placebo. ICurr Clin Pharmacol. 2020. Jonga okungaqondakaliyo.
3. UBjörnsson HK, uBjörnsson ES, uAvula B, okqhubekayo. I-Ashwagandha-eyenzakalisa ukulimala kwesibindi: Uluhlu lwamatyala e-Iceland kunye ne-US yeziyobisi ezenziwa ziiNtsholongwane. Isibindi Int. Ngo-2020; 40: 825-829. Jonga i-abstract.
4. Durg S, Bavage S, Shivaram SB. U-Andania somnifera (i-ginseng yaseIndiya) kwisifo seswekile: Uphononongo olucwangcisiweyo kunye nohlalutyo lwe-meta-ubungqina bobunzululwazi obuvela kuphando lokulinga ukuya kwisicelo seklinikhi. Phytother Res. 2020; 34: 1041-1059. Jonga i-abstract.
5. UKelgane SB, uSalve J, uSampara P, uDebnath K.Ukusebenza kunye nokunyamezelwa kweengcambu ze-ashwagandha kubantu abadala ekuphuculeni impilo kunye nokulala ngokubanzi: Isifundo esilawulwa, esingenamntu, esingaboniyo, esilawulwa yi-placebo. Cureus. 2020; 12: e7083. Jonga i-abstract.
6. UPérez-Gómez J, Villafaina S, Adsuar JC, Merellano-Navarro E, Collado-Mateo D. Iziphumo ze-ashwagandha (Withania somnifera) kwi-VO2max: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta. Izondlo. Ngo-2020; 12: 1119. Jonga i-abstract.
7. I-Salve J, iPate S, i-Debnath K, i-Langade D.I-Adaptogenic kunye ne-anxiolytic yeziphumo ze-ashwagandha yeengcambu ezikhutshiweyo kubantu abadala abasempilweni. Cureus. 2019; 11: e6466. Jonga i-abstract.
8. I-Lopresti AL, Smith SJ, Malvi H, Kodgule R.Uphando malunga nokunciphisa uxinzelelo kunye nezenzo zamayeza e-ashwagandha (Withania somnifera): Isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. Amayeza (iBaltimore). 2019; 98: e17186. Jonga i-abstract.
9. I-Sharma AK, i-Basu I, i-Singh S. Ukusebenza kunye nokhuseleko lwe-Ashwagandha yeengcambu ezikhutshiweyo kwizigulana ze-hypothyroid: ityala elilawulwa kabini elingaboniyo. J Enye into yokuGqibezela iMed. Ngo-2018 uMar; 24: 243-248. Jonga i-abstract.
10. Kumar G, Srivastava A, Sharma SK, Rao TD, Gupta YK. Ukusebenza kunye nokuvavanywa kokhuseleko kunyango lwe-ayurvedic (ashwagandha powder kunye ne-sidh makardhwaj) kwizigulana ze-rheumatoid arthritis: isifundo sombono wenqwelomoya. Indiya J Med Res 2015 Jan; 141: 100-6. Jonga i-abstract.
11. UDongre S, uLangade D, uBhattacharyya S.Ukusebenza kunye nokukhuseleka kwe-ashwagandha (withania somnifera) isicatshulwa sengcambu ekuphuculeni ukusebenza ngokwesondo kwabasetyhini: isifundo somqhubi. I-Biomed Res Int 2015; 2015: 284154.
12. UJahanbakhsh SP, uManteghi AA, uEmami SA, uMahyari S, et al. Ukuvavanywa kokusebenza kwe-withania somnifera (ashwagandha) ingcambu ekhutshwe kwizigulana ezinesifo esinyanzelekileyo: isilingo esilawulwa ngokungahleliwe. Gcwalisa iTher Med ngo-2016 Agasti; 27: 25-9.
13. UChoudhary D, uBhattacharyya S, uJoshi K.Ukulawula ubunzima bomzimba kubantu abadala abaphantsi koxinzelelo olunganyangekiyo ngokunyanga nge-ashwagandha yengcambu: ulingo olulawulwa yimfama, olungenamkhethe, olulawulwa yi-placebo. J Evid esekwe ngokuNcedisayo kwiMed Med. Ngo-2017 uJan; 22: 96-106 Jonga into engabonakaliyo.
14. USud Khyati S, Thaker B. Uphononongo olulawulwayo olungenamakhonkco kabini lwe-ashwagandha kuxinzelelo ngokubanzi loxinzelelo. I-Ayurvedic Med J 2013; 1: 1-7.
15. UChengappa KN, Bowie CR, Schlicht PJ, uFleet D, uBrar JS, uJindal R. Isifundo esilawulwa ngokukuko sokulawulwa kwe-placebo sokukhutshwa kwe-andania somnifera yokungasebenzi kakuhle kwengqondo kwisifo se-bipolar. J Klinikhi yonyango. Ngo-2013; 74: 1076-83. Jonga i-abstract.
16. I-Chandrasekhar K, i-Kapoor J, i-Anishetty S. Isifundo esinokwenzeka, esingalawulekiyo esingacwangciswanga sokhuseleko kunye nokusebenza kwe-high-concentration yoxinzelelo olupheleleyo lweengcambu ze-ashwagandha ukunciphisa uxinzelelo kunye noxinzelelo kubantu abadala. Indiya J Psychol Med. Ngo-2012; 34: 255-62. Jonga i-abstract.
17. IBiswal BM, iSulaiman SA, uIsmail HC, uZakaria H, uMusa KI. Iziphumo zika-Andania somnifera (Ashwagandha) kuphuhliso lwe-chemotherapy-indigue kunye nomgangatho wobomi kwizigulana ezinomhlaza wamabele. Umhlaza oHlanganisiweyo. Ngo-2013; 12: 312-22. Jonga i-abstract.
18. I-Ambiye VR, i-Langade D, i-Dongre S, i-Aptikar P, i-Kulkarni M, i-Dongre A. Uvavanyo lweklinikhi lomsebenzi we-Spermatogenic we-Root Extract ye-Ashwagandha (Withania somnifera) kwi-Oligospermic Male: Isifundo soPhando. Ubungqina bokuSebenza ngokuGqibezela iMed. Ngo-2013; 2013: 571420. Jonga i-abstract.
19. IAgnihotri AP, iSontakke SD, iThawani VR, iSooji A, iGoswami VS. Iziphumo zika-Andania somnifera kwizigulana ze-schizophrenia: isifundo esingenamkhawulo, esingaboniyo kabini, esokuvavanywa kwesilingo somqhubi wenqwelomoya. Indiya J Pharmacol. Ngo-2013; 45: 417-8. Jonga i-abstract.
20. U-Anbalagan K kunye no-Sadique J.U-Andania somnifera (ashwagandha), isiyobisi esivuselelayo esilawula i-alpha-2 macroglobulin synthesis ngexesha lokudumba. Int. J. Inkunkuma yeziyobisi. Ngo-1985; 23: 177-183.
21. IVenkataraghavan S, uSeshadri C, uSundaresan TP, kunye et al. Iziphumo zokuthelekisa ubisi eziqiniswe kunye ne-Aswagandha, i-Aswagandha kunye nePunarnava ebantwaneni-isifundo esingaboni kabini. J Res Ayur Sid 1980; 1: 370-385.
22. UGhosal S, uLal J, uSrivastava R, kunye no-al. Iziphumo ze-Immunomodulatory kunye ne-CNS ye-sitoindosides 9 kunye ne-10, ii-glycowithanolides ezimbini ezivela ku-Andania somnifera. UPhando lwePhytotherapy 1989; 3: 201-206.
23. Upadhaya L kunye et al. Indima yesiyobisi semveli iGeriforte kumanqanaba egazi ee-biogenic amines kunye nokubaluleka kwayo kunyango lwexhala le-neurosis. I-Acta Nerv Super 1990; 32: 1-5.
24. UAhumada F, Aspee F, Wikman G, kunye et al. U-Andania somnifera ukhuphe. Iziphumo zalo kuxinzelelo lwegazi olujikelezayo kwizinja ezingafakwanga. UPhando lwePhytotherapy 1991; 5: 111-114.
25. UKuppurajan K, uRajagopalan SS, uSitoraman R, kunye no-al. Iziphumo ze-Ashwagandha (Withania somnifera Dunal) kwinkqubo yokwaluphala kumavolontiya abantu. Ijenali yoPhando e-Ayurveda naseSiddha 1980; 1: 247-258.
26. UDhuley, J. N. Iziphumo ze-ashwagandha kwi-lipid peroxidation kwizilwanyana ezibangelwa luxinzelelo. J U-Ethnopharmacol. Ngo-1998; 60: 173-178. Jonga i-abstract.
27. UDhuley, J.N.Ukusebenza ngokunyanga kweAshwagandha ngokuchasene nokuvavanywa kwe-aspergillosis kwiimpuku. I-Immunopharmacol kunye neImmunotoxicol. Ngo-1998; 20: 191-198. Jonga i-abstract.
28. Sharada, A. C., Solomon, F. E., Devi, P. U., Udupa, N., kunye no-Srinivasan, K. K. Antitumor kunye ne-radiosensitizing iziphumo ze-withaferin A kwimouse Ehrlich ascites carcinoma in vivo. Acta Oncol. Ngo-1996; 35: 95-100. Jonga i-abstract.
29. UDevi, P. U., Sharada, A. C., noSolomon, F. E. Antitumor kunye neziphumo zeradiosensitizing ze-Andania somnifera (Ashwagandha) kwithumba elinokutshintshwa lempuku, iSarcoma-180. Indiya J Exp Biol. Ngo-1993; 31: 607-611. Jonga i-abstract.
30. I-Praveenkumar, V., Kuttan, R., kunye ne-Kuttan, G.Isenzo sokukhusela iRasayanas ngokuchasene ne-cyclosphamide ityhefu. Tumori 8-31-1994; 80: 306-308. Jonga i-abstract.
31. UDevi, P. U., Sharada, A. C., noSolomon, F. E. Kwi-vivo ukukhula kwe-inhibitory kunye ne-radiosensitizing iziphumo ze-withaferin A kwimouse Ehrlich ascites carcinoma. Umhlaza Lett. 8-16-1995; 95 (1-2): 189-193. Jonga i-abstract.
32. I-Anbalagan, K. kunye ne-Sadique, J. Impembelelo yeyeza laseIndiya (iAshwagandha) kwizigaba zesikhuselo se-acute. Indiya J Exp Biol. Ngo-1981; 19: 245-249. Jonga i-abstract.
33. Malhotra, C. L., Mehta, V. L., Prasad, K., kunye noDas, P. K. Izifundo kwi-Andania ashwagandha, Kaul. IV. Iziphumo zeealkaloids zizonke kwimisipha egudileyo. Indiya J Physiol Pharmacol. Ngo-1965; 9: 9-15. Jonga i-abstract.
34. Malhotra, C. L., Mehta, V. L., Das, P. K., kunye noDhalla, N. S. Izifundo kwi-Andania-ashwagandha, Kaul. V. Iziphumo zee-alkaloids zizonke (ashwagandholine) kwinkqubo ye-nervous system. Indiya J Physiol Pharmacol. Ngo-1965; 9: 127-136. Jonga i-abstract.
35. Begum, V. H. kunye noSadique, J. Iziphumo zexesha elide zeziyobisi ngamayeza kunye no-Andania somnifera kwi-adjuvant eyenze ukuba isifo samathambo senziwe kwiigundane. Indiya J Exp Biol. Ngo-1988; 26: 877-882. Jonga i-abstract.
36. UVaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, SP, Kaul, SC, Sekar, K., kunye noWadhwa, R. Imisebenzi eyahlukileyo kwezi zimbini zinxulumene ngokusondeleyo neanolides, iWithaferin A kunye ne-Andanone: i-bioinformatics kunye nobungqina bovavanyo. IPL. Ngo-2012; 7: 44419. Jonga i-abstract.
37. Sehgal, V. N., Verma, P., kunye neBhattacharya, S. N. Ukuqhuma kweziyobisi okungapheliyo okubangelwa yi-ashwagandha (Withania somnifera): ichiza elisetyenziswa kakhulu le-Ayurvedic. Ulusu. Ngo-2012; 10: 48-49. Jonga i-abstract.
38. Malviya, N., Jain, S., Gupta, V. B., kunye noVyas, S. Izifundo zamva nje ngamayeza e-aphrodisiac kulawulo lokungasebenzi kakuhle ngokwesondo kwamadoda-uphononongo. Acta Pol.Umveliso. Ngo-2011; 68: 3-8. Jonga i-abstract.
39. UVen Murthy, M. R., Ranjekar, P.K, Ramassamy, C., kunye noDeshpande, M.Isiseko sobunzululwazi bokusetyenziswa kwezityalo zonyango lwama-ayurvedic eIndiya kunyango lweengxaki ze-neurodegenerative: ashwagandha. I-Cent.Nerv.Syst.Agents kunye neMedhem. 9-1-2010; 10: 238-246. Jonga i-abstract.
40. Bhat, J., Damle, A., Vaishnav, P. P., Albers, R., Joshi, M., kunye no-Banerjee, G. Kwi-vivo ukwandiswa kwesenzo sokubulala iseli yendalo ngokusebenzisa iti eqiniswe ngamayeza e-Ayurvedic. Umgangatho weRes 2010; 24: 129-135. Jonga i-abstract.
41. UMikolai, J., Erlandsen, A., Murison, A., Brown, K. A., Gregory, W. L., Raman-Caplan, P., kunye noZwickey, H. L. Kwiziphumo ze-Ashwagandha (Withania somnifera) kwizicatshulwa ze-lymphocytes. J. Altern. Ukugcwalisa iMed. Ngo-2009; 15: 423-430. Jonga i-abstract.
42. Lu, L., Liu, Y., Zhu, W., Shi, J., Liu, Y., Ling, W., noKosten, T. R. Amayeza emveli kunyango lweziyobisi. NdinguJ J ukusebenzisa iziyobisi gwenxa ngo-2009; 35: 1-11. Jonga i-abstract.
43. U-Singh, R. H., Narsimhamurthy, K., no Singh, G. Neuronutrient ifuthe lonyango lwe-Ayurvedic Rasayana kunyango lokuguga kwengqondo. Biogerontology. Ngo-2008; 9: 369-374. Jonga i-abstract.
44. UTohda, C. [Ukoyisa izifo ezininzi ze-neurodegenerative ngamayeza emveli: ukukhula kwamayeza onyango kunye nokuvula iindlela ze-pathophysiological]. Yakugaku Zasshi 2008; 128: 1159-1167. Jonga i-abstract.
45. UDeocaris, C., Widodo, N., Wadhwa, R., kunye noKaul, S. C. Ukudibana kwe-ayurveda kunye nezicubu ezisekwe kwinkcubeko yokusebenza kwe-genomics: inkuthazo evela kwiinkqubo zebhayoloji. Inguqulelo kaJ. Ngo-2008; 6: 14. Jonga i-abstract.
46. Kulkarni, S. K. kunye noDhir, A. Andania somnifera: i-ginseng yaseIndiya. Iprog. Neuropsychopharmacol. Biol. I-Psychiatry 7-1-2008; 32: 1093-1105. Jonga i-abstract.
47. IChoudhary, MI, Nawaz, SA, ul-Haq, Z., Lodhi, MA, Ghayur, MN, Jalil, S., Riaz, N., Yousuf, S., Malik, A., Gilani, AH, kunye ne- ur- URahman, A. Withanolides, iklasi entsha ye-inhibitors yendalo ye-cholinesterase inezinto ezichasene necalcium. Biochem Biophys.Res Commun. 8-19-2005; 334: 276-287. Jonga i-abstract.
48. UKhattak, S., Saeed, Ur Rehman, Shah, H. U., Khan, T., kunye no-Ahmad, M. In vitro enzyme inhibition yezinto ezingafunekiyo ezikhutshiweyo ezivela kwizityalo zonyango zasePakistan. Nat.Prod.Res 2005; 19: 567-571. Jonga i-abstract.
49. Kaur, K., Rani, G., Widodo, N., Nagpal, A., Taira, K., Kaul, SC, kunye noWadhwa, R. Uvandlakanyo lwezinto ezichasayo ezichasayo kunye nezinto ezichasayo ezichasayo ezivela kwiqabunga vivo nakwi-vitro ephakanyiswe i-Ashwagandha. Ukutya Chem. Ngo-2004; 42: 2015-2020. Jonga i-abstract.
50. UDevi, P. U., Sharada, A. C., Solomon, F. E., noKamath, M. S. Kwi-vivo ukukhula kwe-inhibitory yesiphumo sika-Andania somnifera (Ashwagandha) kwithumba elinokutshintshwa lempuku, iSarcoma 180. I-Indian J Exp Biol. Ngo-1992; 30: 169-172. Jonga i-abstract.
51. UGupta, S. K., Dua, A., kunye noVohra, B. P. Withania somnifera (Ashwagandha) attenuates antioxidant defense in old spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Ukudibana neziyobisi. Ngo-2003; 19: 211-222. Jonga i-abstract.
52. UBhattacharya, S. K. kunye noMuruganandam, A. V. Umsebenzi we-Adaptogenic ka-Andania somnifera: isifundo esilingwayo kusetyenziswa imodeli ye-rat yoxinzelelo olungapheliyo. I-Pharmacol Biochem. IBehav 2003; 75: 547-555. Jonga i-abstract.
53. UDavis, L. kunye noKuttan, G. Iziphumo zika-Andania somnifera kwi-DMBA eyenze i-carcinogenesis. J U-Ethnopharmacol. 2001; 75 (2-3): 165-168. Jonga i-abstract.
54. UBhattacharya, S. K., Bhattacharya, A., Sairam, K., noGhosal, S. Umsebenzi we-Anxiolytic-antidepressant ka-Andania somnifera glycowithanolides: isifundo sovavanyo. Unyango lwe-2000; 7: 463-469. Jonga i-abstract.
55. I-Panda S, Kar A. Utshintsho kwimilinganiselo yehomoni ye-thyroid emva kolawulo lwe-ashwagandha yeengcambu ezikhutshiweyo kwiimpuku zabantu abadala. J Pharm Pharmacol 1998; 50: 1065-68 (PubMed) (Umnqamlezo) Jonga i-abstract.
56. I-Panda S, Kar A. Withania somnifera kunye neBauhinia purpurea kulawulo lokujikeleza ukugxila kwehomoni yegazi kwiimpuku zabasetyhini. UJ Ethnopharmacol 1999; 67: 233-39. Jonga i-abstract.
57. U-Agarwal R, uDiwanay S, uPatki P, uPatwardhan B.Uphononongo lomsebenzi we-immunomodulatory we-Andania somnifera (Ashwagandha) kwizicatshulwa zokuvavanywa komzimba. J U-Ethnopharmacol 1999; 67: 27-35. Jonga i-abstract.
58. UAhumada F, Aspee F, Wikman G, Hancke J. Andania somnifera exract. Iziphumo zalo kuxinzelelo lwegazi olunezinja kwizinja ezingafakwanga. UPhytother Res 1991; 5: 111-14.
59. I-Kulkarni RR, iPatki PS, iJog VP, okqhubekayo. Unyango lwe-osteoarthritis kunye nokwenziwa kwe-herbomineral: i-blind-blind, i-placebo elawulwa yi-cross-over Study. J U-Ethnopharmacol 1991; 33: 91-5. Jonga i-abstract.
60. UAhmad MK, uMahdi AA, uShukla KK, et al. U-Andania somnifera uphucula umgangatho wobudoda ngokulawula amanqanaba e-hormone okuzala kunye noxinzelelo lwe-oxidative kwi-seminal plasma yamadoda angazaliyo. Ukuchuma kweSteril 2010; 94: 989-96. Jonga i-abstract.
61. Andallu B, Radhika B. Hypoglycemic, diuretic kunye ne-hypocholesterolemic isiphumo se-cherry yasebusika (Withania somnifera, Dunal) ingcambu. Indiya J Exp Biol 2000; 38: 607-9. Jonga i-abstract.
62. I-Sriranjini SJ, i-Pal PK, i-Devidas KV, i-Ganpathy S. Ukuphuculwa kokulinganisela kwi-deceerative cerebellar ataxias emva konyango lwe-Ayurvedic: ingxelo yokuqala. I-Neurol India 2009; 57: 166-71 (PubMed) (Umnqamlezo) Jonga i-abstract.
63. U-Katz M, uLevine AA, uKol-Degani H, uKav-Venaki L.Ulungiselelo lwe-herbal yokulungiselela (CHP) kunyango lwabantwana abane-ADHD: ityala elilawulwa ngokungahleliwe. J Atten Disord 2010; 14: 281-91. Jonga i-abstract.
64. UCooley K, uSzczurko O, uPerri D, et al. Inkathalo ye-Naturopathic yoxinzelelo: ityala elilawulwa ngokungahleliwe ISRC TN78958974. I-PLoS enye ngo-2009; 4: e6628. Jonga i-abstract.
65. I-Dasgupta A, Tso G, Wells A. Iziphumo ze-ginseng yaseAsia, iginseng yaseSiberia, kunye neyeza laseIndiya iAshwagandha kwimilinganiselo ye-serum digoxin nguDigoxin III, omtsha we-digoxin immunoassay. J Iklinikhi yoLwazi ngo-2008; 22: 295-301. Jonga i-abstract.
66. Dasgupta A, Peterson A, Wells A, ugqirha JK. Iziphumo zamayeza eIndiya eAyurvedic eAshwagandha kwimilinganiselo ye-serum digoxin kunye ne-11 yesiqhelo esweni iziyobisi kusetyenziswa ii-immunoassays: ukufundwa kokubopha kweeproteni kunye nokunxibelelana neDigibind. IArch Pathol Lab Med 2007; 131: 1298-303. Jonga i-abstract.
67. UMishra LC, uSingh BB, uDagenais S. Isiseko senzululwazi yokusebenzisa unyango lwe-Andania somnifera (ashwagandha): uphononongo. Enye iMed Rev 2000; 5: 334-46. Jonga i-abstract.
68. Nagashayana N, Sankarankutty P, Nampoothiri MRV, et al. Umbutho we-l-DOPA ngokuchacha ngokulandela amayeza e-Ayurveda kwiSifo sikaParkinson. J Neurol Sci 2000; 176: 124-7. Jonga i-abstract.
69. I-Bhattacharya SK, i-Satyan KS, i-Ghosal S. Umsebenzi we-Antioxidant ye-glycowithanolides evela ku-Andania somnifera. Indiya J Exp Biol 1997; 35: 236-9. Jonga i-abstract.
70. UDavis L, uKuttan G.Ukunyanzeliswa kwetyhefu ye-cyclophosphamide ebangelwa ngu-Andania somnifera kwiimpuku. J U-Ethnopharmacol 1998; 62: 209-14. Jonga i-abstract.
71. IArchana R, Namasivayam A.Impembelelo ye-Antistressor ye-Andania somnifera. J U-Ethnopharmacol 1999; 64: 91-3. Jonga i-abstract.
72. UDavis L, Kuttan G. Iziphumo ze-Andania somnifera kwi-cyclophosphamide-indased urotoxicity. Umhlaza Lett 2000; 148: 9-17. Jonga i-abstract.
73. Upton R, ed. I-Ashwagandha Root (Withania somnifera): Uhlalutyo, ulawulo lomgangatho, kunye ne-therapuetic monograph. ISanta Cruz, CA: I-American Herbal Pharmacopoeia 2000: 1-25.
74. UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ii-eds. Incwadana yokhuseleko lwezityalo yaseMelika. IBoca Raton, FL: ICR Press, LLC 1997.

Ukuhlaziywa okokugqibela-12/16/2020